XCancer Omaha — Omaha, Nebraska

Public research footprint of XCancer Omaha, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Prostate Cancer · Prostatic Neoplasms · mCRPC · Metastasis From Malignant Tumor of Prostate (Disorder)

Recently updated registry entries

NCT07745361 — Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (Recruiting)
NCT07164443 — A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant… (Recruiting)
NCT06014255 — Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at XCancer Omaha?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.